Trelavue

What it is used for

TRELAVUE is indicated for the treatment of Human Immunodeficiency Virus (HIV) infection in adults and adolescents from 12 years of age who are antiretroviral treatment-naïve or are infected with HIV without documented or clinically suspected resistance to any of the three antiretroviral agents (dolutegravir, abacavir or lamivudine) in TRELAVUE.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 30 degrees Celsius
Store in Original Container
Keep Container Tightly Closed/Airtight
Protect from Moisture
Shelf lifetime is 36 Months.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 30 degrees Celsius
Store in Original Container
Keep Container Tightly Closed/Airtight
Protect from Moisture
Shelf lifetime is 36 Months.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Pregnant or planning a pregnancy?

For the active ingredient dolutegravir + abacavir + lamivudine

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.